Nadroparin Sodium Activates Nrf2/HO-1 Pathway in Acetic Acid-Induced Colitis in Rats
- 22 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Inflammation
- Vol. 35 (3), 1213-1221
- https://doi.org/10.1007/s10753-012-9431-z
Abstract
Effects of nadroparin sodium, a low molecular weight heparin, in colitis was investigated by analyzing proteins implicated in nuclear factor E2-related factor-2/heme oxygenase-1 (Nrf2/HO-1) and nuclear factor kappa B (NF-κB) pathways. Twenty-eight rats were used. Colitis was induced by acetic acid (AA). Nadroparin sodium was given to prevention and treatment groups in addition to AA. Colitis was assessed histologically and levels of proteins were analyzed with Western blot. Nadroparin not only prevented and ameliorated the AA-induced colitis histopathologically but also decreased expression of colon NF-κB, activator protein-1, cyclooxygenase-2, tumor necrosis factor-alpha, and IL-6, which were significantly increased in group AA compared to control. The accumulation of Nrf2 in nuclear fraction and HO-1 found low in group AA was increased with nadroparin (p < 0.05). The mean malondialdehyde level increased with AA and was decreased significantly with nadroparin prevention and treatment (p < 0.001). Nadroparin sodium has both protective and therapeutic effects against colonic inflammation via exerting anti-oxidative and anti-inflammatory effects by modulating Nrf2/HO-1 and NF-κB pathways.Keywords
This publication has 48 references indexed in Scilit:
- An Anti-Inflammatory Role for Carbon Monoxide and Heme Oxygenase-1 in Chronic Th2-Mediated Murine ColitisThe Journal of Immunology, 2011
- Persistent Cyclooxygenase-2 Inhibition Downregulates NF-κB, Resulting in Chronic Intestinal Inflammation in the Min/+ Mouse Model of Colon TumorigenesisCancer Research, 2010
- Chronic Cyclooxygenase-2 Inhibition Promotes Myofibroblast-Associated Intestinal FibrosisCancer Prevention Research, 2010
- Neuroinflammation in inflammatory bowel diseaseJournal of Neuroinflammation, 2010
- The role of COX-2 in intestinal inflammation and colorectal cancerOncogene, 2009
- Nrf2:INrf2 (Keap1) signaling in oxidative stressFree Radical Biology & Medicine, 2009
- New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?Gastroentérologie Clinique et Biologique, 2009
- Increased intestinal expression of heme oxygenase‐1 and its localization in patients with ulcerative colitisJournal of Gastroenterology and Hepatology, 2008
- Effects of N-Acetylcysteine Plus Mesalamine on Prostaglandin Synthesis and Nitric Oxide Generation in TNBS-Induced Colitis in RatsDigestive Diseases and Sciences, 2008
- Heparin’s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectinsJCI Insight, 2002